Evoq Remedies (BOM:543500) Debt-to-Equity : 0.05 (As of Sep. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Evoq Remedies Debt-to-Equity?

Evoq Remedies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was ₹12.76 Mil. Evoq Remedies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was ₹0.00 Mil. Evoq Remedies's Total Stockholders Equity for the quarter that ended in Sep. 2023 was ₹248.36 Mil. Evoq Remedies's debt to equity for the quarter that ended in Sep. 2023 was 0.05.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Evoq Remedies's Debt-to-Equity or its related term are showing as below:

BOM:543500' s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.27 Max: 0.45
Current: 0.05

During the past 5 years, the highest Debt-to-Equity Ratio of Evoq Remedies was 0.45. The lowest was 0.00. And the median was 0.27.

BOM:543500's Debt-to-Equity is ranked better than
81.93% of 83 companies
in the Medical Distribution industry
Industry Median: 0.29 vs BOM:543500: 0.05

Evoq Remedies Debt-to-Equity Historical Data

The historical data trend for Evoq Remedies's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evoq Remedies Debt-to-Equity Chart

Evoq Remedies Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Debt-to-Equity

0.05

0.27

0.35

0.39

Evoq Remedies Semi-Annual Data
	Mar19	Mar20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Debt-to-Equity	Get a 7-Day Free Trial			N/A	0.35	0.45	0.39	0.05

Competitive Comparison of Evoq Remedies's Debt-to-Equity

For the Medical Distribution subindustry, Evoq Remedies's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evoq Remedies's Debt-to-Equity Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Evoq Remedies's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Evoq Remedies's Debt-to-Equity falls into.

Evoq Remedies Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Evoq Remedies's Debt to Equity Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(95.762	+	0)	/	247.855
	=	0.39

Evoq Remedies's Debt to Equity Ratio for the quarter that ended in Sep. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(12.759	+	0)	/	248.355
	=	0.05

Evoq Remedies (BOM:543500) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Evoq Remedies Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Evoq Remedies's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Evoq Remedies (BOM:543500) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Evoq Remedies Ltd (BOM:543500) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Science City Road, A-1106, Empire Business Hub, Near AUDA Water Tank, Sola, Ahmedabad, GJ, IND, 380060

Website

http://www.evoqremedies.com

Evoq Remedies Ltd is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, calcium, multivitamins, injections and others. It operates in a single segment that is Pharmaceutical Trading.

Evoq Remedies (BOM:543500) Headlines

No Headlines